Julia Macchione Marujo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Julia Macchione Marujo has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Daniela Gomes Cunha
Oncological Dermatology Service, Instituto Nacional do Câncer, Rio de Janeiro (RJ), Brazil
1 shared publication - Gabriella Campos-Do-Carmo
Oncological Dermatology Service, Instituto Nacional do Câncer, Rio de Janeiro (RJ), Brazil
1 shared publication - Gustavo Costa Verardino
Department of Pathology, Microimagem, Rio de Janeiro, RJ, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 August 2018
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 93 (4) , 576-578
Paraneoplastic Sweet’s syndrome
Sweet’s syndrome is a rare dermatosis with little-known pathogenesis, associated with some clinical conditions such as infections, autoimmune diseases, inflammatory bowel diseases, vaccination, medications and neoplasms. Hematologic malignancies are the diseases most related to paraneoplastic Sweet’s syndrome, but this clinical entity can also be found occasionally in some solid tumors, including genitourinary tract tumors. We report a rare case of paraneoplastic Sweet’s syndrome associated with the diagnosis of cervical cancer.
- 1 August 2018
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 93 (4) , 576-578
Open AccessParaneoplastic Sweet’s syndrome
Sweet’s syndrome is a rare dermatosis with little-known pathogenesis, associated with some clinical conditions such as infections, autoimmune diseases, inflammatory bowel diseases, vaccination, medications and neoplasms. Hematologic malignancies are the diseases most related to paraneoplastic Sweet’s syndrome, but this clinical entity can also be found occasionally in some solid tumors, including genitourinary tract tumors. We report a rare case of paraneoplastic Sweet’s syndrome associated with the diagnosis of cervical cancer.